Chimera is a computational biotechnology venture that aims to develop a specialized CAR-T receptor design pipeline for ovarian cancer immunotherapy using deep-learning models to drastically reduce the candidate search space and experimental costs from the current standard where CAR-T receptor design costs millions of dollars. This grant will allow for initial computational validation of the […]
Read More